Navigation Links
Talyst and RXinnovate Partner on Pharmacy Automation Implementation

BELLEVUE, Wash., Oct. 1 /PRNewswire/ -- Talyst, a leader in pharmacy automation systems, announced today a partnership with RXinnovate, a healthcare consultancy, to offer top-of-the-line implementation services to Talyst's clients in the acute care industry. Talyst recognizes that every hospital is unique and requires a tailored approach that addresses its size, technology, floor plan and workflow.

By partnering with RXinnovate, Talyst is able to broaden its implementation team to include more pharmacists with hands-on implementation experience. RXinnovate will work with Talyst to plan, direct, and facilitate successful implementations. "We have enjoyed a working relationship with RXinnovate for almost a year," said Carla Corkern, Talyst CEO and chairman of the board. "They have proven their ability to ensure the smooth implementation of our products in acute care settings. It's great to make the relationship official. "

RXinnovate is a respected healthcare consultancy with more than 10 years of broad-based experience in acute care hospitals. It has a wide range of technological expertise that encompasses Talyst products and those from healthcare technology providers that interface with Talyst solutions. Its implementation team includes pharmacists with proficiency in information systems configuration, pharmacy wholesale, and legacy hardware.

For further information, please visit or

About Talyst

Talyst is engineering the safer pharmacy. The company was founded in 2002 to provide easy-to-use, automated medication management systems to acute care hospital pharmacies. The following year, Talyst launched AutoPharm®, the innovative software platform designed to integrate medication storage, inventory, ordering, barcoding, and clinical systems.

By 2009, Talyst had installed automated systems in close to 400 acute care hospitals and integrated healthcare companies. By leveraging our expertise in acute care pharmacy automation, we are now building unique systems designed specifically to meet the needs of long-term care facilities and correctional institutions. Talyst is dedicated to delivering world-class software and proven hardware components to enhance efficiency, provide greater inventory control, and improve patient safety in all environments. For more information, see or call 877-4-Talyst (877-482-5978).

About RXinnovate

RXinnovate Consulting was founded in 1999 to provide a broad range of consulting services to hospitals and health systems across the country. Our consulting and implementation teams have over 20 years experience in pharmacy management and the skill sets for designing and implementing major patient care projects for hospitals. RXinnovate's comprehensive consulting portfolio is designed to meet the unique challenges facing hospitals and healthcare systems.


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
5. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
6. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
7. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
8. Catalyst Pharmaceutical Partners Continues Clinical Development of CPP-109 For The Treatment of Cocaine and Methamphetamine Addiction
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
11. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
Post Your Comments:
(Date:6/23/2016)... MEDIA, Pa. , June 23, 2016 ... treatments in an outpatient dialysis facility.  Treatments are usually ... to 6 hours per visit, including travel time, equipment ... on a patient, but especially grueling for patients who ... residents of a skilled nursing and rehabilitation centers for ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
Breaking Medicine Technology:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):